ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,553Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1269

$1.04M Total Retail Price of All Prescriptions

Rank: 21 out of 1269

639 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 639 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 639 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 512 493 1 3
AMLODIPINE BESYLATE 473 465 2 2
METOPROLOL SUCCINATE 366 365 3 13
LEVOTHYROXINE SODIUM 362 350 4 4
METOPROLOL TARTRATE 360 348 5 6
FUROSEMIDE 333 319 6 5
ATORVASTATIN CALCIUM 326 318 7 7
ALENDRONATE SODIUM 291 284 8 28
CRESTOR 284 277 9 25
ZOLPIDEM TARTRATE 283 283 10 19
TRAMADOL HCL 268 250 11 16
HYDROCHLOROTHIAZIDE 226 215 12 10
NEXIUM 222 218 13 41
LISINOPRIL 219 213 14 1
WARFARIN SODIUM 209 202 15 12
OMEPRAZOLE 199 193 16 8
PRAVASTATIN SODIUM 196 188 17 11
ATENOLOL 175 173 18 14
DIOVAN 175 173 18 35
MECLIZINE HCL 174 174 20 140
CITALOPRAM HBR 172 166 21 21
LIDODERM 168 168 22 56
LOSARTAN POTASSIUM 158 150 23 15
PANTOPRAZOLE SODIUM 152 152 24 18
METFORMIN HCL 146 128 25 9
GABAPENTIN 140 128 26 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 118 27 33
PREDNISONE 116 107 28 45
VERAPAMIL ER 108 102 29 134
NAMENDA 107 107 30 38
DONEPEZIL HCL 106 103 31 22
SERTRALINE HCL 106 96 31 23
ALLOPURINOL 102 99 33 49
DIOVAN HCT 100 100 34 76
CELEBREX 95 95 35 95
SYNTHROID 94 94 36 72
PROAIR HFA 88 76 37 61
LANSOPRAZOLE 86 86 38 120
TAMSULOSIN HCL 81 81 39 31
POTASSIUM CHLORIDE 81 76 39 26
ADVAIR DISKUS 78 76 41 46
ISOSORBIDE MONONITRATE ER 73 71 42 63
FLUTICASONE PROPIONATE 73 72 42 40
EXFORGE 70 62 44 181
CIPROFLOXACIN HCL 68 66 45 66
LIPITOR 66 64 46 91
VYTORIN 64 62 47 168
ESCITALOPRAM OXALATE 64 60 47 58
GLIMEPIRIDE 62 57 49 57
RANITIDINE HCL 62 62 49 27
CLOPIDOGREL 60 60 51 32
MEGESTROL ACETATE 59 59 R 52 236
RAMIPRIL 58 53 53 96
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 52 54 84
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 55 59
ACTONEL 55 55 56 229
SPIRIVA 55 45 56 64
VOLTAREN 55 55 56 162
TRIAMCINOLONE ACETONIDE 54 53 59 131
LOVASTATIN 52 52 60 30
EXELON 51 51 61 142
EXFORGE HCT 50 50 62 309
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.